X-linked alpha-thalassemia-intellectual disability syndrome

X-linked alpha-thalassemia-intellectual disability syndrome (ATR-X syndrome) is a rare genetic disorder caused by mutations in the ATRX gene located on the X chromosome. The condition predominantly affects males and is characterized by a distinctive combination of severe intellectual disability, a recognizable pattern of facial features, alpha-thalassemia (a mild form of hemoglobin H disease), and genital abnormalities. The syndrome was first described in the 1980s and is also known as ATR-X syndrome, Alpha-thalassemia X-linked intellectual disability syndrome, or ATRX syndrome. The condition affects multiple body systems. Neurological involvement is prominent, with affected individuals typically having severe to profound intellectual disability, limited or absent speech, and hypotonia (low muscle tone). Characteristic facial features include a small head (microcephaly), telecanthus or hypertelorism (widely spaced eyes), a flat midface, a small triangular upturned nose, tented upper lip, and a prominent lower lip. Genital abnormalities in males range from undescended testes (cryptorchidism) to ambiguous genitalia or hypospadias, reflecting abnormal gonadal development. The alpha-thalassemia component is usually mild, with hemoglobin H inclusions detectable in red blood cells, though clinically significant anemia is uncommon. Additional features may include skeletal anomalies, short stature, seizures, and gastrointestinal problems such as gastroesophageal reflux and constipation. There is currently no cure for ATR-X syndrome. Management is supportive and multidisciplinary, focusing on addressing individual symptoms. This may include speech and physical therapy, management of seizures with anticonvulsant medications, surgical correction of genital abnormalities, and monitoring of feeding difficulties. Carrier females are typically unaffected or very mildly affected due to skewed X-inactivation, though rare cases of mild intellectual disability in carrier females have been reported. Genetic counseling is recommended for affected families.

Common questions about X-linked alpha-thalassemia-intellectual disability syndrome